Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Medical imaging company plays role in clinical trial of drug for breast cancer
March 3rd, 2005
WorldCare Clinical, Inc., a provider of medical imaging solutions for clinical trials, announced that it had provided the imaging core laboratory services for Abraxane Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound), which was approved by the U.S. Food and Drug Administration (FDA) and is indicated for metastatic breast cancer. Abraxine was developed by American Bioscience, Inc. (ABI) and manufactured and marketed by American Pharmaceutical Partners, Inc. (APPX). WorldCare Clinical, Inc. was selected by American Bioscience, Inc to manage the review of computed tomography (CT) scans, radiographs and...
Source: Women's Health Weekly (2005-03-03)
|
